JP2022553709A - 低分子飲料水、調製方法および応用 - Google Patents
低分子飲料水、調製方法および応用 Download PDFInfo
- Publication number
- JP2022553709A JP2022553709A JP2022523643A JP2022523643A JP2022553709A JP 2022553709 A JP2022553709 A JP 2022553709A JP 2022523643 A JP2022523643 A JP 2022523643A JP 2022523643 A JP2022523643 A JP 2022523643A JP 2022553709 A JP2022553709 A JP 2022553709A
- Authority
- JP
- Japan
- Prior art keywords
- water
- molecular
- low
- weight
- drinking water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003651 drinking water Substances 0.000 title claims abstract description 43
- 235000020188 drinking water Nutrition 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 229
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000000889 atomisation Methods 0.000 claims abstract description 12
- 239000001257 hydrogen Substances 0.000 claims description 45
- 229910052739 hydrogen Inorganic materials 0.000 claims description 45
- 238000002347 injection Methods 0.000 claims description 29
- 239000007924 injection Substances 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 26
- -1 hydrogen ions Chemical class 0.000 claims description 23
- 239000008213 purified water Substances 0.000 claims description 13
- 230000005684 electric field Effects 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 8
- 238000001802 infusion Methods 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 7
- 206010012601 diabetes mellitus Diseases 0.000 claims description 5
- 239000003643 water by type Substances 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 2
- 210000004185 liver Anatomy 0.000 claims description 2
- 208000030159 metabolic disease Diseases 0.000 claims description 2
- 239000008223 sterile water Substances 0.000 claims description 2
- 229940116269 uric acid Drugs 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 4
- 230000008092 positive effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000003053 toxin Substances 0.000 description 9
- 231100000765 toxin Toxicity 0.000 description 9
- 108700012359 toxins Proteins 0.000 description 9
- 108091006146 Channels Proteins 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 6
- 210000000170 cell membrane Anatomy 0.000 description 5
- 238000001784 detoxification Methods 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000036571 hydration Effects 0.000 description 4
- 238000006703 hydration reaction Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000008239 natural water Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 206010021024 Hypolipidaemia Diseases 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010047956 Nucleosomes Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 210000001623 nucleosome Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/005—Systems or processes based on supernatural or anthroposophic principles, cosmic or terrestrial radiation, geomancy or rhabdomancy
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/48—Treatment of water, waste water, or sewage with magnetic or electric fields
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Water Supply & Treatment (AREA)
- Environmental & Geological Engineering (AREA)
- Hydrology & Water Resources (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Geology (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
本発明の低分子飲料水は、通常水が以下の低分子水を1以上含むことを特徴とし、その具体的な構造は以下の通りである。
図5に示される調製装置のように、貯水容器10に貯水された通常水は、まず、霧化のために疎水ポンプ20を通って霧化装置30に入り、その後に霧化水路60を通って水素イオン生成領域50に送られ、その後に混合装置40の水素イオン水蒸気混合領域150において混合される。その後、混合された水はプロトン付加水パッケージング装置70に送られて、正電荷を帯びた水素イオンの周りに2、3、4、5または6個の水分子が付着した低分子飲料水が得られる。図4に示すように、水分子は、H2Oを指す。すなわち、正帯電を帯びた水素イオンH+を取り囲む水分子の群から、比較的安定した低分子クラスタが形成される。混合装置40は、多孔質の陰極120によって、水素イオン生成領域50と水素イオン水蒸気混合領域150とに分離されている。本出願において、使いやすさのために、貯水タンク160内の精製水が、小型輸液ポンプ140を通って中空射出針110内に供給される。精製水は先端部の強電場によってってイオン化されて水素イオンを生成する。水素イオンの半径は極めて小さいため、強い電場が形成され、霧化した水の水分子が水素イオン水蒸気混合領域150において吸着され、それにより2、3、4、5、6の小さな水クラスタがプロトンに付着して形成される。低分子群の水が水素イオンのエネルギを有するように、水はプロトンに付着する。そして、水素イオンの静電エネルギの存在に因り、低分子水は4日以上の寿命を有する。
実施形態1の方法によれば、市販の飲料水と処理された水とを比較することによって、図9に示す結果を得ることができた。
本発明に開示された低分子飲料水によれば、関連するボランティア(高空腹時インスリン)が、低分子飲料水を2ヶ月間飲んだ。空腹時インスリンは151.2から49.4に低下し、空腹時グリコシル化ヘモグロビンは6.2から5.3に低下した。
対照群は市販の飲料水を、投与群は低分子飲料水(処理された水)を飲んだ。上図のデータは、糖尿病導入期において、投与群(16.5から17.3)はわずかに0.8だけ増加したが、対照群(14から19.8)は5.8だけ増加したことを示している。
本発明に開示される低分子飲料水によれば、関連するボランティアのトリグリセリドが20年以上にわたって5以上であり、プロトン化した低分子飲料水500ccを4週間毎日飲んだ後、トリグリセリドが5.03から2.52に減少した。
Claims (9)
- 前記通常水が精製水である、請求項1に記載の低分子飲料水。
- 前記低分子飲料水が、10-6mol/L以上の濃度でH+を含有する、請求項1に記載の低分子飲料水。
- 前記通常水が霧化装置(30)によって霧化されて霧化水蒸気を生成し、該霧化水蒸気が霧化水路(60)を通って水素イオン生成領域(50)に供給され、該水素イオン生成領域(50)に中空射出針(110)の針先が配置され、高圧電源(90)が前記中空射出針(110)の針先と穴あき陰極(120)との間に電圧を印加することによって前記中空射出針(110)の針先に強電場を発生させて前記霧化水蒸気がイオン化し正電荷を帯びた水素イオンを生成し、混合装置(40)内の水素イオンが水蒸気混合領域(150)において混合され、混合された水がプロトン水パッケージング装置(70)に輸送されて正電荷を帯びた水素イオンの周りに2、3、4、5または6個の水分子を有する低分子飲料水が得られ、前記混合装置(40)が、穴あき陰極(120)によって水素イオン生成領域(50)と水素イオン水蒸気混合領域(150)とに分割されている、
ことを特徴とする、請求項1に記載の低分子飲料水の調製方法。 - 前記通常水が精製水であり、該精製水は、無菌貯水容器(10)に入れられ、無菌輸液ポンプ(20)を通ってその後の霧化装置(30)によって霧化される、請求項4に記載の低分子飲料水の調製方法。
- 前記低分子飲料水は、
前記水素イオン生成装置(50)が、原料水素(100)を生成するための水素イオンを、ポンプ本体(130)を経由して水素イオン生成領域(50)に供給するために用いられ、中空射出針(110)の針先が水素イオン生成領域(50)に配置され、中空射出針(110)の針先と穴あき陰極(120)との間に高圧電源(90)によって電圧が印加されることによって前記中空射出針(110)の先端に強電場が発生させられて水素がイオン化されて正電荷を帯びた水素イオンを生成し、前記中空射出針(110)の針先の他端が貯水タンク(160)に接続されている、
ことを特徴とする、請求項4に記載の低分子飲料水の調製方法。 - 前記水素イオン生成領域(50)は、小型輸液ポンプ(140)が貯水タンク(160)内の精製水を中空射出針(110)の針先に搬送し、前記中空射出針(110)の針先と前記穴あき陰極(120)との間に高圧電源(90)によって電圧が供給され、中空射出針(110)の針先に強電場が発生させられ、前記中空射出針(110)の針先の水分子がイオン化されて正電荷を有する水素イオンを生成する、
ことを特徴とする、請求項4に記載の低分子飲料水の調製方法。 - 前記霧化装置(30)および前記混合装置(40)の内部空間が、80℃以上の温度に維持される、請求項4に記載の低分子飲料水の調製方法。
- 糖尿病、血中脂肪減少、肝臓保護、生体内血中尿酸減少を含む代謝性疾患の治療への請求項1に記載の低分子飲料水の応用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911005058.4 | 2019-10-22 | ||
CN201911005058.4A CN110902785A (zh) | 2019-10-22 | 2019-10-22 | 一种小分子饮用水和制备方法及应用 |
PCT/CN2020/113125 WO2021077913A1 (zh) | 2019-10-22 | 2020-09-03 | 一种小分子饮用水和制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022553709A true JP2022553709A (ja) | 2022-12-26 |
JP7470189B2 JP7470189B2 (ja) | 2024-04-17 |
Family
ID=69814969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022523643A Active JP7470189B2 (ja) | 2019-10-22 | 2020-09-03 | 低分子飲料水および方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220363573A1 (ja) |
EP (1) | EP4049979A4 (ja) |
JP (1) | JP7470189B2 (ja) |
KR (1) | KR20220086642A (ja) |
CN (1) | CN110902785A (ja) |
WO (1) | WO2021077913A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110902785A (zh) * | 2019-10-22 | 2020-03-24 | 杭州善上水科技有限公司 | 一种小分子饮用水和制备方法及应用 |
CN116287056B (zh) * | 2023-04-04 | 2023-11-07 | 广州源潮生物信息技术有限公司 | 一种植物多糖及其提取方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008117387A1 (ja) * | 2007-03-23 | 2008-10-02 | Kuki-Shoukou, Co., Ltd. | 還元水生成装置 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1300113A (zh) * | 1999-12-16 | 2001-06-20 | 金城集团有限公司 | 富氢燃料改质器 |
JP2007330844A (ja) * | 2006-06-12 | 2007-12-27 | Takeshi Toba | 水の水質改質方法およびその装置 |
AT12981U1 (de) * | 2006-11-13 | 2013-03-15 | Josef Peter Dr Guggenbichler | Stoff mit antimikrobieller wirkung |
US8679351B2 (en) * | 2009-12-30 | 2014-03-25 | Hydrover Holding S.A. | Process and apparatus for decontaminating water by producing hydroxyl ions through hydrolysis of water molecules |
TW201201900A (en) * | 2010-05-27 | 2012-01-16 | Eiji Matsumura | Liquid clathrate with gas molecule dissolved therein in high density |
CN202142497U (zh) * | 2011-06-10 | 2012-02-08 | 上海大学 | 产生质子转移反应初始水合氢离子的多尖端放电离子源 |
CN103145289B (zh) * | 2011-12-07 | 2015-09-09 | 睿福股份有限公司 | 氢离子及氢氧离子混合物的制造方法 |
CN104230091B (zh) * | 2013-08-29 | 2017-08-08 | 吉林天士力矿泉饮品有限公司 | 一种制备稳定小分子团水的水处理方法及系统 |
EP3286137A4 (en) * | 2015-04-23 | 2019-01-30 | Lawrence Carlson | STABLE ELECTROLYTE MATERIAL THEREWITH |
KR20180102045A (ko) * | 2015-07-03 | 2018-09-14 | 타이그러스, 엘엘씨 | 국소 또는 표면 처리 조성물의 특성을 향상시키기 위한 물질 |
CN205907054U (zh) * | 2016-03-29 | 2017-01-25 | 韩秉叡 | 可改善人体病源中和自由基和抗氧化的氢分子水生成器 |
CN206204073U (zh) * | 2016-10-21 | 2017-05-31 | 郑秋景 | 一种超小分子团饮用水生成设备 |
CN106542683A (zh) * | 2016-12-09 | 2017-03-29 | 通威股份有限公司 | 一种利用磁场和电场制备小水分子团水的工艺 |
CN110902785A (zh) * | 2019-10-22 | 2020-03-24 | 杭州善上水科技有限公司 | 一种小分子饮用水和制备方法及应用 |
-
2019
- 2019-10-22 CN CN201911005058.4A patent/CN110902785A/zh active Pending
-
2020
- 2020-09-03 EP EP20879181.4A patent/EP4049979A4/en active Pending
- 2020-09-03 WO PCT/CN2020/113125 patent/WO2021077913A1/zh unknown
- 2020-09-03 KR KR1020227017007A patent/KR20220086642A/ko not_active Application Discontinuation
- 2020-09-03 US US17/642,421 patent/US20220363573A1/en active Pending
- 2020-09-03 JP JP2022523643A patent/JP7470189B2/ja active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008117387A1 (ja) * | 2007-03-23 | 2008-10-02 | Kuki-Shoukou, Co., Ltd. | 還元水生成装置 |
Also Published As
Publication number | Publication date |
---|---|
EP4049979A1 (en) | 2022-08-31 |
CN110902785A (zh) | 2020-03-24 |
US20220363573A1 (en) | 2022-11-17 |
JP7470189B2 (ja) | 2024-04-17 |
KR20220086642A (ko) | 2022-06-23 |
EP4049979A4 (en) | 2023-11-15 |
WO2021077913A1 (zh) | 2021-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6733434B2 (en) | Method and apparatus for electromagnetically restructuring ingestible substances for organismic consumption | |
JP2022553709A (ja) | 低分子飲料水、調製方法および応用 | |
KR20080080483A (ko) | 통합 코일 장치 및 이를 이용하는 방법 | |
CN106362202B (zh) | 一种具有微电流和药物缓释作用的水凝胶及制备方法与应用 | |
JP2016533326A (ja) | スキンの複層組織に渡る分子デリバリのための方法及び装置 | |
Ahmadi et al. | Fullerene effect on chemical properties of antihypertensive clonidine in water phase | |
Luo et al. | Regulating the production and biological function of small extracellular vesicles: current strategies, applications and prospects | |
CN107619085A (zh) | 一种小分子能量水的制备装置及方法 | |
CN109513000A (zh) | 一种运载蜂毒肽的光敏性纳米载体制备方法及应用 | |
TWI842030B (zh) | 小分子飲用水及其製備方法及應用 | |
RU2244573C2 (ru) | Способ обеспечения косметической/медицинской терапии | |
WO2000014019A1 (fr) | Eau medicale active, sa fabrication et son utilisation | |
Khamoushian et al. | Transdermal delivery of insulin using combination of iontophoresis and deep eutectic solvents as chemical penetration enhancers: In vitro and in vivo evaluations | |
CN103990136A (zh) | 经皮给药系统及其制备方法和应用 | |
Nandy et al. | Water in Health, Disease and Power Generation: From Literature to Hypotheses. | |
CN110200818A (zh) | 一种量子能量面膜贴的制备工艺 | |
TW202404905A (zh) | 小分子飲用水及其製備方法及應用 | |
CN209024353U (zh) | 一种十五级弱碱山泉机 | |
KR101967725B1 (ko) | 입자에너지 다기능 활성수 제조용 복합재, 제조방법 및 장치 | |
Steve Haltiwanger | The Electrical Properties of Cancer Cells | |
CN107383166A (zh) | 对痤疮杆菌敏感的肽 | |
KR20090087519A (ko) | 미세결합수를 함유하는 혼합한방추출액의 제조방법 | |
KR20130135803A (ko) | 토션장 전사방법 및 그 장치 | |
KR20120100436A (ko) | 토션장 전사방법 및 그 장치 | |
KR20210000323U (ko) | 고농도 원자수소 발생기를 활용한 수(水)소 미전수기 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220615 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220615 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230627 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231107 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240122 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240319 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240405 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7470189 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |